Inspire Veterinary Partners : Material Event Form 8 K

Item 8.01 Other Events.

As previously reported, Inspire Veterinary Partners, Inc. (the "Company") had a hearing date with the Nasdaq Hearings Panel (the "Panel") on May 14, 2024.

On June 6, 2024, the Company received a letter from the Panel indicating that our request for continued listing on Nasdaq was granted subject to the following: (i) on or before June 15, 2024, the Company shall file a registration statement with the Securities and Exchange Commission for a public offering that will be led by Spartan Capital Securities, LLC, and (ii) on or before September 4, 2024, the Company shall demonstrate compliance with Listing Rule 5550(b)(1).

Additionally, the Company was advised that September 4, 2024, represents the full extent of the Panel's discretion to grant continued listing while the Company is non-compliant with Nasdaq's Listing Rules. It is a requirement during the exception period that we provide prompt notification of any significant events that occur during this time that may affect our compliance with Nasdaq requirements.